ITGB2 and pancreatic neoplasm: In summary, the results of these studies indicate that the inhibition of Rac1, either by NSC23766 or expression of N17Rac1, augments the sensitivity of CD18/HPAF pancreatic cancer cells to IR, whereas it has little effect on the sensitivity of HPNE normal cells to IR.